Heterogeneity in chemoresponsiveness of ovarian cancer as demonstrated by an ex vivo chemo response assay

5059 Background: Only a subset of patients responds to a given chemotherapeutic regimen. The purpose of this analysis was to determine whether tumors are generally sensitive or resistant regardless...